Long-term Safety and Efficacy of the Anti-MAdCAM-1 Monoclonal Antibody Ontamalimab [SHP647] for the Treatment of Ulcerative Colitis: The Open-label Study TURANDOT II.
J Crohns Colitis
; 15(6): 938-949, 2021 Jun 22.
Article
in En
| MEDLINE
| ID: mdl-33599720
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Colitis, Ulcerative
/
Cell Adhesion Molecules
/
Drug Monitoring
/
Antibodies, Monoclonal, Humanized
/
Mucoproteins
Type of study:
Clinical_trials
/
Diagnostic_studies
Limits:
Adult
/
Female
/
Humans
/
Male
Language:
En
Journal:
J Crohns Colitis
Journal subject:
GASTROENTEROLOGIA
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: